about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroIn vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneCiprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidisCiprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureusChemotherapeuticsComparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.Pharmacokinetics of ciprofloxacin in cystic fibrosis.In vitro antibacterial activity of Q-35, a new fluoroquinoloneIn vitro activity of Bay 12-8039, a new 8-methoxyquinolone.Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophiliaComparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocciEfficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazoleEffect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urineCiprofloxacin penetration into extravascular spaces in a rabbit model.Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography.Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.In vitro activity of ciprofloxacin combined with azlocillin.Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidCross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.In vitro activity of Bay y 3118, a new quinolone.The inoculum effect and band-pass bacterial response to periodic antibiotic treatment.In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrASteady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disksA review of the antimicrobial activity of the fluoroquinolones.Quinolone antibacterial agents for the treatment of genitourinary tract infections.Inhaled antibiotics for gram-negative respiratory infections.Aeromonas as a human pathogen.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Overview of clinical experience with ciprofloxacin.
P2860
Q24670241-410E26C4-2A6E-4D30-8F59-A6BA264F22E3Q24685787-A0318CA4-A8D7-42F3-B9A3-0B90D26D8461Q28334677-4ACDE23F-E2F5-489B-BB7B-F5A54DFD2C56Q28361123-1D376217-43D8-4203-A283-2FC01658FEDEQ30047670-380F2A55-5E96-4AF6-9BBC-3F455288ABBAQ30451302-0CCF8DDB-4B88-43F9-AAE3-B9BB96C32EFAQ33741046-F254EDD1-ECEE-4604-974F-95E8A4B873A8Q34537973-69B2179C-7271-4269-8025-4D4A7F8AB444Q35137842-B22A4342-8163-44EE-B6C6-DBA3F80113DFQ35291821-AFCF0FFA-55E4-49EE-9167-256517F94695Q35303163-305A0F7F-8B66-485B-BB10-E0EC7411B512Q35306777-FCE2BD57-5D8E-4D0D-B36C-B4AC4F911D10Q35361659-24699C0E-4FFE-45A4-9F77-7BE845A4192AQ35536165-5B8F90EC-B820-4638-B491-3496C5F27F58Q35543422-AF37BEFD-0C84-4303-BEB5-440CB1B7970BQ35568734-3BA6F33A-9C90-4B22-AF75-BA93B2BBA831Q35568914-BF5616FB-BB79-4F43-974E-690A82917462Q35570539-874891E0-F97E-43DF-901B-278167450672Q35570563-0A50E85F-9BE2-4207-8B47-EC23BCB027BAQ35641275-C0F0EC8E-61EA-4F2E-A585-B51D2F9B88F4Q35642422-B00535CF-AC6B-452C-9965-CC20AC9050C8Q35643824-7B3996EA-AD4B-4A22-85CA-A1EBC3B9E53BQ35646379-893F7D5B-55B1-4C8A-9CE6-16742B61BFC3Q35648175-E01FCFF8-8A99-466B-BEB3-AD5CC33901F4Q35650708-58D1040E-99AD-4C2F-9943-D991FD2B7FABQ35653930-75EAC088-A14B-4CC9-9DF3-8ABF93B9DE68Q35760077-2BDDB8DA-882A-451D-95AF-C02E26E13AB4Q35760862-29A4B60B-073D-4CCF-9EA0-37CB8FFAA8A9Q35899898-B7212262-8D31-4D43-AEED-0EF5870E5EF3Q36321625-7FC8376F-5816-4929-B3AF-1C91437D60E3Q36456932-65CC9B59-E5D1-4ED6-9873-967AEADB9353Q36753750-5709459C-6575-4907-8E29-CBE14F33AF93Q36757441-CDE0D151-94B0-485F-AA85-11C605833F1AQ37281766-92B2BCE3-969B-4B73-8133-E5381AD87B7CQ37834318-E7B6B5AB-10F8-4ECE-8CBB-7F7F862BFCDEQ37897445-3B6DDD72-7434-476F-BDB4-055038FA531AQ37937558-D65DC2F3-1F25-47DC-9A56-E05E116B13A4Q38614071-DD1885C3-4A16-4635-B900-EE017711153CQ39214819-5EBE90AF-7F64-4244-B01D-5ABD8387C57CQ39502910-8A02969C-9597-427E-B469-445492A51E66
P2860
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
In vitro activity of ciprofloxacin (Bay o 9867)
@ast
In vitro activity of ciprofloxacin (Bay o 9867)
@en
type
label
In vitro activity of ciprofloxacin (Bay o 9867)
@ast
In vitro activity of ciprofloxacin (Bay o 9867)
@en
prefLabel
In vitro activity of ciprofloxacin (Bay o 9867)
@ast
In vitro activity of ciprofloxacin (Bay o 9867)
@en
P356
P1476
In vitro activity of ciprofloxacin (Bay o 9867)
@en
P2093
P2860
P304
P356
10.1128/AAC.24.4.568
P407
P577
1983-10-01T00:00:00Z